Cargando…
Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to a late diagnosis and poor response to available treatments. There is a need to identify complementary treatment strategies that will enhance the efficacy and reduce the toxicity of currently used therapeutic approaches. W...
Autores principales: | Mohammad, Jiyan, Dhillon, Harsharan, Chikara, Shireen, Mamidi, Sujan, Sreedasyam, Avinash, Chittem, Kishore, Orr, Megan, Wilkinson, John C., Reindl, Katie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828188/ https://www.ncbi.nlm.nih.gov/pubmed/29535819 http://dx.doi.org/10.18632/oncotarget.23623 |
Ejemplares similares
-
Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage
por: Dhillon, Harsharan, et al.
Publicado: (2014) -
Overexpression of peptide deformylase in breast, colon, and lung cancers
por: Randhawa, Harsharan, et al.
Publicado: (2013) -
Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways
por: Singh, Rahul R., et al.
Publicado: (2020) -
Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016) -
Synteny mapping between common bean and soybean reveals extensive blocks of shared loci
por: McClean, Phillip E, et al.
Publicado: (2010)